Cytox Raises £600,000
Cytox Ltd., a UK-based provider of biomarker services for Alzheimer's disease clinical trials, has raised £600,000 in seed funding. Backers include MASA Life Sciences and Midven Ltd.
24 June 2009•4 mins read
Cytox Ltd., a UK-based provider of biomarker services for Alzheimer's disease clinical trials, has raised £600,000 in seed funding. Backers include MASA Life Sciences and Midven Ltd.
